Related Experiment Videos
[Pathogenesis of acute hypercapnic hyperammoniaemia (author's transl)]
Respiration; International Review of Thoracic Diseases
|January 1, 1979
Summary
Drug-induced changes in portal pressure affect ammonia levels. Oxprenolol reduced ammonia by constricting the portal system, while phentolamine temporarily increased it.
Area of Science:
- Pharmacology
- Physiology
- Toxicology
Context:
- Ammonia (NH3) is a critical metabolite, and its elevated levels in arterial blood can lead to hepatic encephalopathy.
- The portal-to-systemic venous shunt plays a significant role in ammonia transport and detoxification.
- Understanding how drugs affect portal hemodynamics is crucial for managing ammonia metabolism.
Purpose:
- To investigate the impact of drugs altering portal hemodynamics on arterial ammonia concentrations.
- To examine the influence of hypercapnia on ammonia levels and the portal-to-systemic shunt.
- To assess the effects of oxprenolol (vasoconstrictor) and phentolamine (vasodilator) on ammonia metabolism in dogs.
Summary:
- Studies in anesthetized dogs demonstrated that hypercapnia opens the portal-to-systemic shunt, increasing arterial ammonia (NH3) and cerebrospinal fluid (CSF) ammonia.
- Portal vasoconstriction induced by oxprenolol functionally eliminated the shunt, decreasing arterial and CSF NH3 levels.
- Phentolamine-induced vasodilation transiently increased arterial NH3 during normoxia but had no effect during hypercapnia.
Impact:
- This research elucidates the relationship between portal hemodynamics, hypercapnia, and ammonia metabolism.
- Findings highlight the potential of targeting portal pressure for managing hyperammonemia.
- Provides insights into the differential effects of vasoconstrictors and vasodilators on ammonia levels in physiological and pathological conditions.